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Abstract
Here, we describe an engineering approach to quantitatively compare migration, morphologies, and adhesion for
tumorigenic human fibrosarcoma cells (HT-1080s) and primary human dermal fibroblasts (hDFs) with the aim of
identifying distinguishing properties of the transformed phenotype. Relative adhesiveness was quantified using self-
assembled monolayer (SAM) arrays and proteolytic 3-dimensional (3D) migration was investigated using matrix
metalloproteinase (MMP)-degradable poly(ethylene glycol) (PEG) hydrogels (“synthetic extracellular matrix” or
“synthetic ECM”). In synthetic ECM, hDFs were characterized by vinculin-containing features on the tips of
protrusions, multipolar morphologies, and organized actomyosin filaments. In contrast, HT-1080s were characterized
by diffuse vinculin expression, pronounced β1-integrin on the tips of protrusions, a cortically-organized F-actin
cytoskeleton, and quantitatively more rounded morphologies, decreased adhesiveness, and increased directional
motility compared to hDFs. Further, HT-1080s were characterized by contractility-dependent motility, pronounced
blebbing, and cortical contraction waves or constriction rings, while quantified 3D motility was similar in matrices with
a wide range of biochemical and biophysical properties (including collagen) despite substantial morphological
changes. While HT-1080s were distinct from hDFs for each of the 2D and 3D properties investigated, several
features were similar to WM239a melanoma cells, including rounded, proteolytic migration modes, cortical F-actin
organization, and prominent uropod-like structures enriched with β1-integrin, F-actin, and melanoma cell adhesion
molecule (MCAM/CD146/MUC18). Importantly, many of the features observed for HT-1080s were analogous to
cellular changes induced by transformation, including cell rounding, a disorganized F-actin cytoskeleton, altered
organization of focal adhesion proteins, and a weakly adherent phenotype. Based on our results, we propose that
HT-1080s migrate in synthetic ECM with functional properties that are a direct consequence of their transformed
phenotype.
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Introduction
To successfully metastasize, tumor cells must leave the
primary tumor and then navigate numerous tissue barriers
before establishing secondary tumors at distant sites [1-3],
motivating efforts to elucidate mechanisms of 3-dimensional
(3D) migration and invasion [4-14]. Tumor cells have been
characterized by the capacity to transition between distinct
migration modes in 3D culture [4,5], an inherent plasticity that
may enable invasion through diverse extracellular matrix
(ECM) barriers [12-14]. While tumor cell migration modes have
been compared to normal motile cell types such as fibroblasts
or immune cells [12-14], transformation to an aggressive
tumorigenic phenotype profoundly disrupts signaling pathways
[1-3] and cellular properties that mediate motility [15,16],
including cytoskeletal organization [17-22], reorganized
vinculin-containing adhesions [22-26], perturbed integrin
function [27-30], and decreased adhesiveness [26,30-36]. The
3D microenvironment also plays a critical role in maintenance
of normal tissue architecture [37-41], while increased
proliferation, loss of tissue polarity, and transition to an invasive
phenotype have been correlated to ECM influences on ERK
and Rho/Rho-kinase (ROCK) signaling, cytoskeletal tension,
focal adhesion structure, and integrin clustering [42-45].
Therefore, invading tumor cells migrate through mechanisms
that are governed by vastly complex intracellular and
extracellular signals, presenting a major challenge towards
identifying therapeutic targets to treat metastatic cancers.
Researchers have increasingly investigated tumor biology
using in vitro culture platforms derived from ECM materials
such as collagen or Matrigel to model the 3D microenvironment
[40,41]. However, while naturally derived materials mimic the
complexity of the ECM (e.g., fibrillar structure), they offer only
limited control over properties that are often highly variable [46]
or poorly-defined [47]. Synthetic 3D culture platforms address
limitations inherent to naturally-derived materials by providing
strictly defined matrix properties and have been used to
investigate a wide variety of biological questions [10,48-53].
Engineered 3D models have been used to systematically
investigate several questions in tumor biology [10,11,54-62],
including the influence of biochemical and/or biophysical matrix
properties on tumor cell migration or growth [10,11,54-56],
spatiotemporal regulation of invasion by stromal cells [57], and
drug response in 3D environments [54,58]. Therefore,
engineering approaches complement naturally-derived culture
platforms by enabling researchers to deconstruct the diverse
signals of the 3D microenvironment and to systematically
investigate critical factors that contribute to tumor progression
[59-62].
HT-1080 fibrosarcoma cells (HT-1080s) are a human
tumorigenic cell type [63-67] commonly used to model 3D
tumor cell motility [5-11]. While fibrosarcoma tumors are
mesenchymal in origin [68], we previously identified differences
in 3D migration and morphologies for HT-1080s and human
dermal fibroblasts (hDFs, a primary mesenchymal cell type
[69]) that motivated the current study [10]. We hypothesized
that HT-1080s were distinct from hDFs due to a malignant
phenotype [65-67,70] that disrupts several signaling pathways
and functional characteristics important for migration [63,64].
To test our hypothesis, we quantitatively compared adhesion
properties, migration, and morphologies for HT-1080s and
hDFs using defined 2D [71] and 3D [10,50] culture platforms.
HT-1080s were characterized by 2D and 3D features that
differed substantially from primary hDFs, but which were
consistent with changes induced by transformation, including
diffuse vinculin expression [22-26], decreased adhesiveness
[26,30-36], and a cortically organized F-actin cytoskeleton
[17-22]. Further, rounded and elongated HT-1080s and
WM239a melanoma cells migrated through cortical
contractility-driven mechanisms and expressed prominent
uropod-like structures that were similar to features previously
reported for melanoma and breast carcinoma cell lines [72-76].
Therefore, while HT-1080s were characterized by a phenotype
that differed from hDFs in 2D and 3D culture, we identified
distinct features that were similar to aggressive tumorigenic cell
types with diverse tissue origins. Based on our results, we
propose that 3D migration mechanisms for aggressive
tumorigenic cell types are distinct from primary cells due to
cellular changes induced by transformation.
Materials and Methods
Cell culture
HT-1080s (ATCC, Manassas, VA) were cultured in Alpha
MEM (Lonza) supplemented with 10% fetal bovine serum
(FBS, Gibco) and 1% penicillin/streptomycin (Gibco). For 2D
experiments on self-assembled monolayers, primary human
dermal fibroblasts (hDFs) were purchased from ATCC and
cultured in Alpha MEM (Mediatech, Manassas, VA) containing
10% FBS (Invitrogen) and 1% penicillin/streptomycin (Penn/
Strep). Primary hDFs used for 3D studies were kindly provided
by Professor R. Rivkah Isseroff [77], Department of
Dermatology, University of California-Davis and cultured in
Dubellco’s Modified Eagle’s Medium (DMEM, Gibco)
supplemented with 10% FBS, 1% Penn/Strep, and 0.2%
fungizone. WM239a melanoma cells [78] were cultured without
antibiotics in RPMI supplemented with 10% FBS. Plasmids
expressing MCAM-GFP were previously described [79]. For
DNA transfection, cells were trypsinized, resuspended in
growth medium (WM239a cells, RPMI + 10% FBS; HT-1080s
Alpha MEM + 10% FBS), washed once and then resuspended
in OptiMEM. Typically, 100 μL of transfection complex (1 μg
DNA, 10 μL Fugene, 100 μL OptiMEM) was added to 6 well
plates (8 x104 cells / 2 mL) and incubated overnight at 37°C.
After overnight incubation, the media was replaced with fresh
growth medium.
Synthetic ECM preparation
For 3D culture, synthetic extracellular matrix (synthetic ECM)
was formed through photoinitiated coupling of thiol groups and
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alkenes (a “thiol-ene” reaction [80,81]) to incorporate cysteine-
containing peptides into a poly(ethylene glycol) (PEG) matrix
(Figure 1A) [50]. Synthetic ECM crosslinks were formed with a
matrix metalloproteinase (MMP)-degradable peptide that was
modified from an amino acid sequence found in collagen
[82,83], while pendant peptides presenting the fibronectin-
derived amino acid sequence RGD (Arg-Gly-Asp) were
incorporated into the matrix for adhesion [84,85]. The RGD
amino acid sequence was chosen as an adhesion ligand (in
both 2D and 3D) since it binds several integrins important for
motility [84,85]. Synthetic ECM formed using thiol-ene
chemistry provides a well-defined 3D culture platform that is
flexible towards incorporation of any biomolecule containing a
thiol group and has previously been shown to be biocompatible
with a variety of cell types [10,50-53].
Cell migration experiments using synthetic extracellular
matrix (synthetic ECM) and details associated with synthesis of
4-arm poly(ethylene glycol) (PEG)-norbornene monomer and
peptides were previously described in detail [10,50]. Briefly,
synthetic ECM monomer solutions were prepared in PBS as a
2.5 wt% or 3 wt. % (all wt% values by mass, wt/wt) solution of
4-arm PEG-norbornene (MW 20,000) + MMP-degradable
peptide cross-linker (MMP-degradable amino acid sequence:
KKCGGPQG*IWGQGCKK, active sequence in bold [82,83]).
2.5 wt% and 3.0 wt% hydrogels corresponded to 140 and 220
Pa shear modulus, respectively (measured as previously
described [50]). The amino acid sequence CRGDS (active
sequence in bold) was incorporated for adhesion [84,85] and
the scrambled non-bioactive amino acid sequence CRDGS
(mutant sequence italicized) was added to maintain a constant
total pendant peptide concentration of 1.5 mM (pendant
peptides not included in wt% calculation). Finally, 0.05 wt%
final concentration Irgacure 2959 (Ciba) was included as a
photoinitiator. To encapsulate cells, a cell pellet was
suspended in monomer solution at 200,000 cells/mL, and 30
μL aliquots were added to the cut end of a 1 mL syringe tip (BD
Biosciences 1 mL insulin syringe, 29 G x ½ in.) and
polymerized under ~10 mW cm-2, ~352 nm centered UV light
(XX series UVP lamp) for 3 minutes. The polymerized
hydrogels were then suspended in appropriate media and
allowed to swell overnight before beginning experiments.
Inhibitors
Cell migration is limited to proteolytic mechanisms in
synthetic ECM due to a small mesh size (10s of nm) [10,50].
We verified that synthetic ECM prevented non-proteolytic
HT-1080 migration by exchanging normal culture media used
for swelling overnight with media containing 10 μM GM6001
protease inhibitor (Millipore, 364206-1MG) (Movie S1) or equal
volume of DMSO (control) for the duration of the experiment.
Similar results were observed using Marimastat (Millipore,
444289-5mg). For myosin II or ROCK inhibition experiments,
we added media containing 10 μM Y-27632 (ROCK inhibitor in
PBS) or blebbistatin (10-50 μM, with equal volume DMSO for
control) after swelling, and exposed cells to inhibitor solutions
for the duration of the experiment. Time-lapse imaging began 2
hours after adding inhibitors.
Collagen preparation
Collagen was prepared for migration experiments at a final
density of 1.7 - 3.5 mg/mL (quantified motility for 1.7 mg/mL
density) using a 1:1 mixture of high concentration type I rat tail
collagen (BD Biosciences, HC Collagen, 354249) and 100 mM
HEPES buffer in 2X PBS, with 1X PBS or serum free AMEM
added to dilute to the final density (dependent on starting
concentration provided by manufacturer). A cell pellet was re-
suspended at a final concentration of 200,000 cells / mL and
200 μL of the cell/collagen mixture was added to the bottom of
a 48-well plate (BD Biosciences). The collagen gels were
formed by incubating (37° C, 5% CO2) for 60 minutes, after
which serum-containing media was added and cell/collagen
constructs were allowed to incubate overnight before beginning
time-lapse imaging.
Self-assembled monolayer arrays
We quantified adhesiveness for hDFs and HT-1080s using
self-assembled monolayer (SAM) arrays [86] prepared as
previously described in detail for other adherent cell types,
without any changes in procedure [71]. Briefly, adhesion was
promoted using the active RGD-containing peptide
GWGGRGDSP (RGD, active sequence in bold) and
GWGGRGESP (RGE, mutant italicized), where replacement of
aspartic acid (D) with glutamic acid (E) provides a non-
bioactive peptide to balance the total peptide density on each
spot (5% total RGD + RGE). HT-1080s and hDFs were seeded
onto SAM arrays (~1500 cells / cm2; ~32,000 cells / 60 mm
dish) formed with individual RGD-functionalized spots
surrounded by non-adhesive poly(ethylene glycol)-terminated
regions. The size of each spot was 1.1 mm (diameter), and the
maximum total cell density at 5% RGD for hDFs was ~30 cells/
spot. Cells were allowed to attach for ~ 1 hr in a humidified
incubator at 37 °C and 5% CO2, slowly dipped in warm media
(in a 50 mL conical vial) to remove loosely attached cells, and
then submerged in warm media contained in a rectangular
multidish (Thermo Scientific/Nunc, Rochester, NY). Cell
attachment was determined by the average number of cells per
RGD spot (2 arrays, 7 total spots / RGD density on each array,
total N = 14 spots / RGD condition). Minimum RGD density for
attachment was based on a statistical increase relative to the 0
RGD (5% RGE) control condition. SAM arrays enabled efficient
determination of relative adhesiveness for HT-1080s and hDFs
since RGD densities spanning over three orders of magnitude
were simultaneously investigated (0.002%-5% RGD mol
fraction) on a single chip [71].
Immunofluorescence (IF) imaging
F-actin was fluorescently tagged using TRITC-conjugated
phalloidin (Sigma or Millipore. 1:100 dilution) and nuclei were
stained using DAPI (either from focal adhesion kit at 1:500
dilution, Millipore, or in Prolong Gold Antifade mounting
solution as received). Antibodies used were as follows: Mouse
anti-vinculin monoclonal antibody (Clone 7F9, 1:100 dilution),
which was included as part of a focal adhesion staining kit
(Millipore, FAK100), mouse anti-integrin beta 1 monoclonal
antibody (Clone 4B7R, Abcam ab3167, 1:20 dilution), rabbit
anti-Myosin IIB non-muscle antibody (Sigma, M7939-.2ML,
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Figure 1.  Morphologies and cytoskeletal structure for HT-1080 fibrosarcoma cells (HT-1080s) and primary human dermal
fibroblasts (hDFs) in synthetic extracellular matrix (ECM).  (A) Schematic representation of synthetic extracellular matrix
(synthetic ECM) formed through “thiol-ene” photopolymerization chemistry to couple norbornene C=C bonds on 4-arm poly(ethylene
glycol) (PEG) molecules with thiol (-SH) bonds of cysteine-containing peptides. Crosslinks were formed using matrix
metalloproteinase (MMP)-degradable peptides with cysteine groups on each end while adhesion was promoted using pendant
RGD-containing peptides (CRGDS) with a single cysteine (2.5 or 3 wt% by mass PEG-NB + MMP-degradable crosslinking peptide,
shear moduli = 140 Pa or 220 Pa respectively). Constant total pendant peptide was maintained using non-bioactive CRDGS (1500
μM active CRGDS + non-active CRDGS).
(B-I) Projected z-stack immunofluorescence (IF) images illustrating hDFs and HT-1080s seeded in synthetic ECM (220 Pa, 1000 μM
CRGDS). All overlay images are counterstained with TRITC-conjugated phalloidin (F-actin, red) and DAPI (nuclei, blue). (B,C)
Overview to illustrate morphological differences (F-actin, red; Nuclei, blue) for (B) hDFs and (C) HT-1080s. (D-F) IF images
illustrating myosin IIb expression for hDFs: (D) Overlay image (Myosin IIb, green; F-actin, red; Nuclei, blue); Single channel images
(grayscale) illustrate (E) F-actin and (F) Myosin IIb. White arrows point to actomyosin filaments. (G-I) IF images illustrating myosin
IIb expression for HT-1080s: (G) Overlay (Myosin IIb, green; F-actin, red; Nuclei, blue); Single channel images (grayscale) illustrate
(H) F-actin and (I) Myosin IIb.
(J-L) Comparison of quantified mean (J) circularity and (K) elongation for hDFs and HT-1080s calculated using Nikon NIS Elements
software (n > 150 cells, ≥ 6 hydrogels, at least two separate experiments; *** = p<0.001). (L) Fraction of elongated (Elongation ≥
3.0), middle (2.0 ≤ Elongation < 3.0), and rounded (Elongation < 2.0) cells. Differences in fraction of elongated and rounded hDFs
compared to HT-1080s were each statistically significant (N ≥ 6 total gels, at least two separate experiments; *** = p<0.001).
doi: 10.1371/journal.pone.0081689.g001
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1:100-1:500 dilution), mouse anti-MCAM (P1H12, Santa-Cruz
Biotechnology), mouse monoclonal anti-Cdc2 (Santa Cruz
Biotechnoloty, sc-54, 1:100 dilution), and mouse monoclonal
anti-MMP14 (Abcam, ab56307, 1:100 dilution). Secondary
antibodies used were either Alexa-Fluor 488 goat anti-rabbit
(Invitrogen, A-11008) or goat anti-mouse (Invitrogen, A-11001)
IgG (both used at 1:200 dilution).
IF staining followed the procedure provided for a focal
adhesion staining kit (Millipore, FAK100). For 3D IF staining,
we modified the procedure by expanding incubation times to
account for diffusion within the poly(ethylene glycol) (PEG)
hydrogels used to form our synthetic ECM. Cells within
synthetic ECM hydrogels were fixed using 4% formaldehyde in
PBS for 30 minutes. Following fixing, arrays were washed 3
times with wash buffer (0.05% Tween 20, 3 x 15 minute
incubation for each rinse). Next, cells were permeabilized using
0.1 % Triton X-100 in PBS for 30 minutes, followed by
additional rinsing with wash buffer (3 x 15 min.). Gels were
then blocked using 1% (w/w) bovine serum albumin (BSA,
Fisher Scientific) for 2 hours. Primary antibody solutions were
then prepared in blocking solution (1% BSA), added to gels,
and incubated overnight at 4° C. After rinsing with wash buffer
(3 x 30 minutes, extra time to ensure all primary antibodies
were removed), a solution prepared in PBS containing
secondary antibody, TRITC-conjugated phalloidin, and DAPI
was applied overnight at 4° C. The final rinse was in PBS
rather than wash buffer (3 x 30 minutes, gels were left in PBS
at 4° C until use, typically within 48 hours of preparation). For
some myosin II images, cells within synthetic ECM were fixed
with 2% buffered paraformaldehyde (30 minutes), blocked and
permeabilized using 0.25% Triton X-100 and 1% BSA in PBS
(60 minutes), incubated with primary myosin II antibody (1:500,
0.05% Triton X and 1% BSA in PBS; 4° C overnight), washed
three times (2 x 15 min., final rinse overnight at 4° C, 0.05%
Triton X in PBS), incubated with secondary antibody (1:200
antibody, 1:500 DAPI and 1:500 phalloidin, 0.05% Triton X and
1% BSA in PBS; 4° C, 4 hours), and thoroughly washed to
allow excess antibodies to diffuse from hydrogel (1 hr. 0.05%
Triton X in PBS., overnight in PBS).
For IF imaging in synthetic ECM, gels were placed on a
glass slide and surrounded by a 1 mm silicone rubber gasket
(McMaster-Carr, with a hole formed using a 5 mm tissue
punch). The thickness of the hydrogel was slightly higher than
the gasket, creating a tight seal when a coverslip was placed
on top (the gasket prevented the gel from being flattened).
Most IF images in synthetic ECM were collected in 8-bit multi-
track mode (Wavelengths: 488 nm on one track, 405 and 543
nm on the other) with an LSM 710 (Zeiss) confocal microscope
using a 40X W Plan-Apochromat objective (1.0 DIC M27) or a
20X W Plan-Apochromat objective (1.0 DIC M27). Some IF
images for myosin II were collected using a Nikon A1R
confocal microscope (courtesy of Prof. Randolph Ashton,
University of Wisconsin-Madison). All 3D images were
displayed as flattened z-projections (Zeiss Image Browser,
maximum transparency; NIS elements, maximum intensity
projection) unless otherwise noted. Intensity profiles were
generated using the ImageJ “Plot Profile” function, while false-
color intensity images were generated with the “Interactive 3D
Surface Plot” plugin [87-89] or using the LSM Image Browser.
Quantifying migration and morphologies
Quantified 3D migration in synthetic ECM was determined
using an automated Nikon TE2000-E inverted microscope,
controlled with Metamorph software, and a Nikon
environmental chamber with external heater (In vivo Scientific)
and CO2 regulator (In vivo Scientific) to control temperature
(37° C) and CO2 (5%) levels. Quantified attachment to self-
assembled monolayers and migration in collagen gels were
determined using an automated Nikon Ti-E inverted
microscope, controlled with NIS Elements (Nikon) software,
and a Tokai Hit stage top incubation system to control
temperature (37° C) and CO2 (5%) levels.
Time-lapse microscopy was used to track cells in synthetic
ECM for 6 hours (15 minute increments) and analyzed for
quantified migration and morphologies using MetaMorph or
NIS-Elements (Nikon) software. Quantified migration was
determined by tracking cells using 2D minimum intensity
projections of z-stacks (10 μm slices, middle 500 μm of ~1000
μm thick hydrogels). The position of a non-cellular feature
within the hydrogel was tracked and then subtracted from each
cell position to correct for drift. A migrating cell in synthetic
ECM and collagen was defined as having traveled a distance
greater than one cell length from the starting position anywhere
on the 2D projected cell track during the 6 hours of analysis.
One cell length was defined based on the value determined for
hDFs using morphology analysis (NIS Elements) in our base
synthetic ECM formulation (220 Pa, 1000 μM CRGDS, see
Figure 1H) and was applied for all 3D migration analysis. Cells
that interacted or divided were not included in analysis. The
same 6 hour time course was used for control cells and cells
treated with inhibitors. Imaging began 2 hours after adding
fresh media with or without inhibitors (and after overnight
swelling in control media). Reported values for experiments in
synthetic ECM represent a 3D correction for 2D minimum
intensity z-projections used for tracking (multiplied by a factor
of √3/2, migration was assumed to be independent of x,y, or z
direction). Directionality (DTO/TD, Distanct-to-origin / Total
distance) is a dimensionless parameter that provides a
measure of directional motility analogous to persistence time
[90] (Figure S1A).
NIS Elements was used to quantify morphologies from the
outline for the best focus of each cell using the “Draw Object”
feature, from which circularity, elongation, and other
measurements reported here were calculated with the
“Automated Measurement” feature. Circularity is a function of
area and perimeter (Circularity = 4π*area/perimter2) that is
maximum for a circle (Circularity = 1). Elongation represents
the ratio of MaxFeret / MinFeret defined by NIS Elements
(approximately the ratio of the long axis to the short axis of the
cell), and was used to further classify cells into categories
defined as rounded (EI < 2.0), middle (2.0 ≤ EI < 3.0), and
elongated (EI ≥ 3.0), similar to a method previously described
for HT-1080s in collagen [6]. Some movies and time-lapse
images used for display were corrected for drift using the
StackReg plugin (“Translation” function) [91] for ImageJ
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[87,88]. All statistical analysis was performed using a two-tailed
student’s t-test. All error bars represent standard error of the
mean (SEM) unless otherwise noted.
Results
HT-1080 fibrosarcoma cells (HT-1080s) and human
dermal fibroblasts (hDFs) have distinct phenotypes in
2D and 3D culture
We first investigated cytoskeletal organization and quantified
morphologies due to the distinct rounded appearance for
HT-1080s compared to hDFs in 3D culture (Figure 1, Figure
S2). In synthetic ECM, hDFs were characterized by
cytoskeletal properties that were similar to primary fibroblasts
in naturally-derived [92-97] and synthetic [98] ECM materials,
including elongated, multipolar morphologies and F-actin dense
protrusions (Figure 1B). Further, hDFs formed organized
actomyosin filaments with co-localized F-actin and myosin II
(Figure 1D-F, arrows) in synthetic ECM, which was consistent
with previously studies using a variety of 3D culture platforms
[92-98]. In contrast, HT-1080s adopted rounded or spindle
shaped morphologies (Figure 1C) characterized by a cortically
organized F-actin cytoskeleton and myosin II that was diffusely
expressed throughout the cytoplasm (Figure 1G-I). A
quantitative comparison of morphologies (see Methods)
demonstrated that HT-1080s were characterized by increased
circularity (Figure 1J), decreased elongation (Figure 1K), a
higher fraction of rounded cells (Figure 1L), a lower fraction of
elongated cells (Figure 1L), and a shorter average cell length
(Figure S1D) than hDFs. Thus, HT-1080s were characterized
by distinct cytoskeletal structure and a quantitatively more
rounded phenotype than hDFs.
HT-1080s also had distinct adhesion characteristics
compared to hDFs (Figure 2). hDFs were characterized by
vinculin-rich features on the tips of protrusions (Figure 2A) and
β1-integrin spots throughout the cell (Figure 2H, Figure S3) in
synthetic ECM, which resembled adhesion structures
previously described for fibroblasts in 3D culture [94,95,99].
HT-1080s expressed vinculin diffusely throughout the
cytoplasm in synthetic ECM (Figure 2E), which was consistent
with reported expression in collagen [9], but contrasted with the
defined features observed for hDFs. HT-1080s expressed β1-
integrin as condensed features on the tips of protrusions and
on rear end uropod-like structures (Figure 2K, Figures S4-S5),
which was also distinct from adhesions observed for hDFs.
Next, we compared attachment of HT-1080s and hDFs to
RGD-functionalized self-assembled monolayers (RGD-SAMs,
Figure 2N) to provide a quantitative measure of adhesiveness.
Fewer HT-1080s attached to RGD-SAMs than hDFs for all
RGD densities investigated. HT-1080s also required >25-fold
higher RGD density than hDFs to attach to RGD-SAMs (0.19%
RGD for HT-1080s, 0.007% RGD for hDFs, see Methods).
Results for hDF adhesion here were similar to human
mesenchymal stem cells (hMSCs) and human umbilical vein
endothelial cells (HUVECs) that we previously compared using
identical RGD-SAM array formulations [71]. Therefore,
HT-1080s were less adhesive than several primary human cell
types and were characterized by distinct adhesion properties
compared to hDFs in both 2D and 3D environments.
Finally, HT-1080s migrated with distinct movement and a
more polarized morphology when compared to hDFs (Figure 3;
Movies S2-S4). Whereas hDFs were characterized by
elongation, attachment, cell body translocation, and rear
release (Figure 3A), HT-1080s migrated with prominent cell
body contraction (white dashed lines and arrows, Figure 3B)
and protrusion extension that was primarily limited to the
leading edge (Figure 3B, red dashed lines and arrows). A
comparison of quantified migration demonstrated that cell
speed was similar for HT-1080s and hDFs (Figure 3C).
However, HT-1080s migrated with increased directionality
(Figure 3D, Distance-to-Origin/Total Distance, “DTO/TD”),
which led to a substantially higher fraction of migrating cells
than hDFs (Figure 3E, Figure S1E). Collectively, our results
indicated that HT-1080s were more polarized than hDFs in
synthetic ECM, which was reflected qualitatively in
morphologies and protrusion dynamics, and quantitatively by
increased directional migration and a relatively more motile
phenotype. Taken together, HT-1080s were characterized by
expression of adhesion proteins, adhesiveness, cytoskeletal
organization, morphologies and motility that differed
substantially from hDFs.
Rounded and elongated HT-1080s migrate through
cortical contractility-driven proteolytic mechanisms in
synthetic ECM
Contractility and hydrostatic pressure-driven processes
played an important role for driving HT-1080 migration through
both rounded and elongated morphologies in synthetic ECM
(Figures 4-5, Figures S5-S6). Blebs or bleb-like features were
prominent for HT-1080s in synthetic ECM (Figure 4, Figures
S5-S6; Movies S5, S6, S7), including on the cell body (Figure
4A-C), along leading protrusions (Figure 4D-F), and at the tips
of protrusions (Figure 4G). Blebs were also observed on RGD-
SAMs (Figure 4H; Movie S8), suggesting that hydrostatic
pressure played a role for 2D motility [100,101]. Inhibition of
Rho-kinase (ROCK) reduced the fraction of HT-1080s
migrating in synthetic ECM (Figure 4I), indicating that migration
was contractility-dependent. HT-1080s also formed constriction
rings or “cortical contraction waves” [102-104] in synthetic ECM
(Figure 5A; Movie S3) and collagen (Figure 5B; Movie S9),
which was consistent with mechanisms previously described
for immune cell [100-107] and tumor cell [5,108] motility.
Myosin II expression was elevated in bulged regions and
appeared to be depleted in constrictions between them for
HT-1080s in synthetic ECM (Figure 5C-I), while Blebbistatin (a
myosin II inhibitor) induced a mostly non-motile phenotype
(Movie S10). HT-1080s lacking visible protrusions were still
highly motile in synthetic ECM (Figure 6A-C; Movies S11,S12),
and similar migration modes were observed for WM239a
melanoma cells (Figures 6D, 7D; Movie S13). Rounded
migration modes were observed for HT-1080s in synthetic
ECM immediately after encapsulation (Figure 6C; Movie S12),
which confirms the requirement for proteolysis since cell tracks
that would enable non-proteolytic motility had not been formed.
Based on these results, we conclude that both rounded and
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Figure 2.  Comparison of adhesion properties for HT-1080s and hDFs.  (A-M) Projected z-stack immunofluorescence (IF)
images for hDFs and HT-1080s in synthetic ECM (220 Pa, 1000 μM CRGDS). All overlay images are counterstained with TRITC-
conjugated phalloidin (F-actin, red) and DAPI (nuclei, blue).
(A-D) IF images illustrating vinculin expression for hDFs (boxed region from A shown in B-D): (A) Overlay image (Vinculin, green; F-
actin, red; Nuclei, blue). White arrows point to regions enriched with vinculin. (B) Overlay (Vinculin, green; F-actin, red); Single
channel images (grayscale) illustrate (C) F-actin and (D) Vinculin. (E-G) IF images illustrating vinculin expression for HT-1080s: (E)
Overlay image (Vinculin, green; F-actin, red; Nuclei, blue). Single channel images (grayscale) illustrate (F) F-actin and (G) Vinculin.
(H-J) IF images illustrating β1-integrin expression for hDFs: (H) Overlay (β1-integrin, green; F-actin, red; Nuclei, blue); Single
channel images (grayscale) illustrate (I) F-actin and (J) β1-integrin (White arrows point to punctate β1-integrin features; Also Fig.
S3). (K-M) IF images illustrating β1-integrin expression for HT-1080s: (K) Overlay (β1-integrin, green; F-actin, red; Nuclei, blue);
Single channel images (grayscale) illustrate (L) F-actin and (M) β1-integrin.
(N) Comparison of attachment for hDFs and HT-1080s on RGD-SAMs as a function of RGD density. Attachment was statistically
significant (cell number > 0 RGD control spots) for HT-1080s on surfaces with ≥ 0.19% mol fraction RGD and for hDFs on surfaces
≥ 0.007% mol fraction RGD. Error bars represent standard error of the mean (SEM) for array spots at given RGD density.
Significance for cell attachment on individual spots was calculated for hDFs relative to HT-1080s (* = p<0.05; ** = p<0.01; *** =
p<0.001).
doi: 10.1371/journal.pone.0081689.g002
Tumor Migration Mechanism has Unique Properties
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e81689
Figure 3.  Qualitative and quantitative migration for HT-1080s and hDFs.  Time-lapse images (10 min./frame) illustrating
migration for (A) an hDF and (B) an HT-1080 in synthetic ECM (220 Pa, 1000 μM CRGDS). Image sequences in (A,B) are contrast
and brightness enhanced for better display (see Movies S2, S3 for unaltered images, Movie S4 for overview comparison of many
cells). (A) Migration movement for hDF is characterized by: 1. Front end extension, 2. Attachment, 3. Cell body contraction, and 4.
Rear-end release. (B) HT-1080 movement illustrates cell body contraction (white dashed lines and arrow) and simultaneous front
end extension (red dashed lines and arrow).
(C-E) Comparison of quantified 3D migration for HT-1080s and hDFs in synthetic ECM (220 Pa and 1000 μM CRGDS): (C) Cell
speed (adjusted by a factor of √3/2, which was a 3D correction for analysis on 2D minimum intensity z-projections), (D) directionality
(DTO/TD), and (E) fraction migrating cells. DTO/TD is a dimensionless parameter that provides a measure of directional motility
analogous to persistence time (Fig. S1A) that is calculated as the distance-to-origin (DTO) after 6 hours divided by the total path
length (total distance, TD) (shown schematically, panel to right of C). Migration was calculated from images collected in 15 min.
increments for 6 hours, with dividing or interacting cells excluded (≥200 cells, ≥ 3 separate experiments, ≥ 9 total hydrogels). Box
and whisker plot for cell speed: White diamond = mean, white line = median, boxes = middle upper (top) and middle lower (bottom)
quartile of the cell population, whiskers = highest (above) and lowest (below) migration speeds. Values for DTO/TD represent the
mean for all cells while fraction migrating represents the mean for replicate experiments (N ≥ 3). Significance was calculated for hDF
relative to HT-1080 migration for each parameter (*** = p<0.001).
doi: 10.1371/journal.pone.0081689.g003
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elongated tumor cells migrate through cortical contractility-
dependent proteolytic mechanisms.
HT-1080s were characterized by condensed F-actin and β1-
integrin on rear-end features in synthetic ECM (Figure 2K,
Figures S4-S5) that were similar to distinct uropod-like
structures previously described for tumor cells migrating in 3D
matrices [72-75]. Melanoma cell adhesion molecule (MCAM/
cd146/MUC18) is a component of a “Wnt-Receptor-Actin-
Myosin-Polarity (W-RAMP)” structure that mediates polarity
and protrusion retraction [79], and was previously identified on
a uropod-like structure for WM239a melanoma cells in
synthetic ECM [72]. Therefore, we compared MCAM
expression for HT-1080s and WM239a cells to investigate a
potential role for the uropod-like structure for tumor cells
migrating in synthetic ECM. As was observed for HT-1080s,
WM239a cells were characterized by condensed F-actin and
β1-integrin on rear-end uropod-like features in synthetic ECM
(Figure 7A-C, Figure S7). GFP-MCAM transfected WM239a
cells adopted rounded morphologies and migrated with the
MCAM feature pinned at the rear (Figure 7D; Movie S13),
which is in agreement with our previous results [72]. MCAM
was also expressed on the front and rear for non-transfected
WM239a cells (Figure 7E-G) and for both GFP-expressing and
control HT-1080s in synthetic ECM (Figure 7H, Figure S7C-D).
Thus, MCAM played a dynamic role for tumor cells migrating in
synthetic ECM, and was a prominent feature on the uropod-like
structure for rounded and elongated migration modes.
Quantified HT-1080 migration was weakly-dependent
on biochemical and biophysical properties despite
substantially altered morphologies
To determine the influence of 3D ECM properties on tumor
cell motility (Figures 8-9, Figure S1), we compared quantified
migration and morphologies for HT-1080s as a function of
adhesion ligand density (250-1500 μM RGD), mechanical
properties (220 Pa or 140 Pa), and culture platform (synthetic
ECM compared to collagen). HT-1080 motility required RGD-
mediated adhesion in synthetic ECM since cells were non-
motile when RGD was replaced with non-bioactive RDG (Movie
S14). HT-1080s migrated with weak RGD-dependence for cell
speed (Figure 8A) and directionality (Figure 8B) in synthetic
ECM, while results were similar in lower modulus synthetic
ECM (140 Pa) compared the higher modulus (220 Pa)
formulation (Figure S1). Finally, HT-1080 morphologies
became more rounded (or less elongated) with decreasing
RGD concentration or matrix modulus (Figure 8C). Strikingly,
HT-1080s migrated in lower modulus synthetic ECM (Figure
9A; Movie S15) and collagen (Figure 9B; Movie S9) with
statistically equivalent quantified speed (Figure 9C) and
directionality (Figure 9D) despite an ~1.8-fold change in
circularity (Figure 9E) and ~2.5-fold difference in the fraction of
rounded cells (Figure 9F). Therefore, quantified HT-1080
motility was weakly influenced by changes in biochemical and
biophysical properties of the ECM, even when morphologies
were substantially altered.
Discussion
HT-1080 fibrosarcoma cells (HT-1080s) are a malignant cell
type [63-67] commonly studied as a model for 3D tumor cell
motility [5-11]. While fibrosarcoma tumors are mesenchymal in
origin [68], we previously identified differences in motility
compared to primary human dermal fibroblasts (hDFs) [10],
which we hypothesized was due to disrupted function induced
by the transformed phenotype [63-67,70]. To test our
hypothesis, we used engineered 2D [71] and 3D [10,50] culture
platforms to quantitatively compare migration, morphologies,
and adhesiveness for HT-1080s and hDFs. HT-1080s differed
substantially from hDFs for each of the qualitative and
quantitative features investigated, including migration,
morphologies, adhesiveness, expression of adhesion proteins,
and cytoskeletal structure. These differences were not limited
to synthetic ECM, as HT-1080s were also distinct from hDFs
when cultured in collagen (Figure S2) and on tissue culture
polystyrene or RGD-functionalized self-assembled monolayer
arrays (Figure S8). Our results demonstrate that HT-1080s are
characterized by a distinct phenotype compared to primary
hDFs in 2D and 3D culture.
Transformation to a malignant phenotype induces profound
changes in cytoskeletal structure that include pronounced
rounding, loss of organized F-actin filaments, and diffuse
myosin expression [17-22]. Several previous studies have
demonstrated that fibroblasts retain organized cytoskeletal
structure in 3D culture [93-98], and hDFs in synthetic ECM
were similarly characterized by spread, multipolar
morphologies and organized actomyosin filaments (Figure 1).
In contrast, HT-1080s adopted relatively more rounded
morphologies than hDFs in synthetic ECM, and were
characterized by cortically organized F-actin and delocalized
expression of myosin II (Figures 1, 4-5), while morphological
differences were also evident in collagen (Figure S2). Our
results were not limited to 3D culture, as rounding and cortical
F-actin organization became pronounced for HT-1080s on
RGD-SAMs, especially at lower RGD densities where hDFs
retained spread morphologies and organized F-actin structure
(Figure S8). Therefore, HT-1080s were characterized by
rounded morphologies and cortically organized F-actin that
contrasted with hDFs in 2D and 3D culture, suggesting that
these changes in cytoskeletal structure were representative of
an inherent phenotype.
Transformation also induces reorganized vinculin-containing
adhesions [22-26] and perturbs integrin function [27-30], while
decreased adhesiveness is a defining property for malignant
cells [26,30-36]. In synthetic ECM, hDFs expressed vinculin in
condensed features on the tips of protrusions (Figure 2), which
is consistent with 3D adhesions described for fibroblasts in
naturally-derived materials [94,95,99]. In contrast, HT-1080s
were characterized by delocalized vinculin expression and β1-
integrin on the tips of leading protrusions in synthetic ECM
(Figure 2, Figures S4-S5), which agrees with previous results
in collagen [5,9]. While HT-1080s expressed β1-integrin on
protrusions in synthetic ECM, migration was minimally
dependent on adhesion (Figure 8, Figure S1) and cells
remained highly motile after treatment with combinations of β1-
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Figure 4.  Blebbing and contractility-dependent motility for HT-1080s in 2D and 3D culture.  (A-F) Projected z-stack
immunofluorescence (IF) images for HT-1080s in synthetic ECM (220 Pa, 1000 μM CRGDS). Overlay images are counterstained
with TRITC-conjugated phalloidin (F-actin, red) and DAPI (nuclei, blue). Arrows point to apparent blebs or cortex rupture. (A)
Overlay image (Myosin IIb, green; F-actin, red; Nucleus, blue). Unprocessed (top) and brightness enhanced (bottom) single channel
images (grayscale) illustrate (B) F-actin and (C) myosin IIb. (D) Overlay image (β1-integrin, green; F-actin, red; Nucleus, blue) for a
cell migrating into the plane; Single channel images (grayscale) illustrate (E) F-actin and (F) β1-integrin.
Time-lapse images illustrating apparent bleb formation (arrows) for HT-1080s migrating (G) in synthetic ECM (220 Pa, 1000 μM
CRGDS; 10 min / frame, See also Movies S5, S6) and (H) on a 1.7% mol. fraction RGD-SAM surface (30 sec / frame, See also,
Movie S8). (I) Fraction of HT-1080s migrating in synthetic ECM (220 Pa, 1000 μM CRGDS): Control (black) and treated with ROCK
inhibitor (white, 10 μM Y27632). See Movie S10 for treatment with myosin II inhibitor (Blebbistatin). Significance was calculated for
average fraction of cells migrating per hydrogel (11 hydrogels, 4 separate experiments; *** = p<0.001). Scale bars = 25 μm unless
otherwise noted.
doi: 10.1371/journal.pone.0081689.g004
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Figure 5.  Contractile movement for HT-1080s in 3D culture.  (A) Propagation of a constriction ring (arrow) for an HT-1080
migrating in synthetic ECM (220 Pa, 1000 μM CRGDS; 10 min / frame, see also Movie S3). (B) Propagation of a constriction ring
(arrow) for an HT-1080 migrating in collagen (1.7 mg/mL; 15 min./frame, see also Movie S9). Scale bars = 25 μm.
(C-G) Z-projected immunofluorescence images illustrating myosin IIb expression for an HT-1080 in synthetic ECM (220 Pa, 1000
μM CRGDS): (C) Overlay image illustrating myosin IIb (green), counterstained with TRITC-conjugated phalloidin (F-actin, red) and
DAPI (nucleus, blue). Single channel images (grayscale) illustrate (D) F-actin and (E) Myosin IIb. Profile plots generated using
ImageJ “Interactive 3D Surface Plot” function (“Spectrum” intensity scale, projection for middle 3 planes) illustrate (F) F-actin and
(G) Myosin IIb. Two consecutive single plane images (grayscale) illustrate (H) F-actin and (I) Myosin IIb.
doi: 10.1371/journal.pone.0081689.g005
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and β3-integrin blocking antibodies (Figure S4). HT-1080s
were also quantitatively less adhesive than several primary
adherent human cell types, as they required a higher RGD
density for attachment to RGD-SAMs than hDFs here (Figure
2), as well as human mesenchymal stem cells (hMSCs) and
human umbilical vein endothelial cells (HUVECs) that we
previously investigated on identical arrays [71]. Transformation
by Rous sarcoma virus was previously reported to reduce
adhesiveness on fibronectin-coated surfaces by altering β1-
integrin affinity [29], and the weakly-adherent properties for
HT-1080s suggests that they also present integrins in a low
affinity or otherwise altered state [27-30]. Our combined results
demonstrate that HT-1080s were characterized by a
reorganized F-actin cytoskeleton and altered adhesion
characteristics compared to primary human adherent cells,
which is consistent with a mechanistic role for properties of the
transformed phenotype in driving 3D migration.
Normal and tumorigenic cell types migrate through non-
proteolytic, contractility-dependent mechanisms that facilitate
traction without requirements for strong matrix adhesion
[5,100-108], and our results suggest that HT-1080s migrate in
synthetic ECM through analogous proteolytic mechanisms.
Expansion and contraction of large bleb-like bulging
protrusions correlated with cell body movement for HT-1080s in
synthetic ECM (Figure S6; Movie S6), which resembled
amoeboid mechanisms for inserting pseudopodia into existing
matrix gaps to generate traction (e.g., “chimneying”)
[100-102,105-107]. However, HT-1080s must generate their
own matrix gaps in synthetic ECM (Movie S1), and MT1-MMP
expression on bulged leading protrusions (Figure 6) suggested
a role for expansion of these bleb-like features in proteolysis
(Movie S6). HT-1080s were also characterized by diffuse
myosin II expression on the cell body and in discrete bulges
along leading protrusions (Figure 5, Figure S6), while
pronounced blebbing was observed throughout the cell (Figure
4, Figure S5; Movies S5, S7), which is consistent with a cortical
contractility-driven mechanism for generating hydrostatic forces
at the front and rear [101]. Finally, HT-1080s formed
constriction rings (Figure 5; Movie S3) or less pronounced
periodic membrane folds (Figure S6; Movie S6) that remained
fixed relative to the matrix and propagated from the front to the
rear in synthetic ECM (also collagen; Movie S9), which
resembled cortical contraction waves [102-104] or cortical actin
waves [109]. Taken together, our results demonstrate that
cortical contractility played a diverse role for proteolytic
HT-1080 motility in synthetic ECM, which may have broader
implications for understanding how tumor cells navigate dense
matrices.
Tumor cells form pronounced uropod-like structures that play
a role in polarization for contractility-dependent migration in 3D
culture [72-75]. Both rounded and elongated HT-1080s and
WM239a cells formed similar uropod-like structures that were
enriched with melanoma cell adhesion molecule (MCAM/
cd146/MUC18), β1-integrin, and F-actin (Figure 7, Figure S7).
Figure 6.  Rounded proteolytic migration modes for tumor cells in synthetic ECM.  Rounded tumor cells migrating in synthetic
ECM (220 Pa, 1000 μM CRGDS): (A) Time-lapse images (15 min / frame; See also Movie S11) for a rounded HT-1080 after
overnight swelling (day 1). (B) β1-integrin expression (immunofluorescence) for a rounded HT-1080. (C) Time-lapse images (10
min / frame; See also Movie S12) for a rounded HT-1080 shortly after encapsulation (Initial migration, Day 0). (D) Time-lapse
images (30 min / frame) for a rounded WM239a melanoma cell after overnight swelling (day 1). Scale bars = 25 μm unless
otherwise noted.
doi: 10.1371/journal.pone.0081689.g006
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MCAM has been implicated in several mechanisms critical to
tumor cell motility and metastasis [110-113], and was identified
as a component of a “Wnt-receptor-actin-myosin-polarity
(WRAMP)” structure that was linked to polarization and
protrusion retraction for WM239a cells [72,79]. The uropod-like
structure for melanoma cells has also been correlated to
invasion in vitro [73-75] and lung colonization in vivo [73],
which is notable since MCAM functions as a cell-cell adhesion
molecule for endothelial cells [114] and has been implicated in
homing and extravasation [115,116]. Migrating GFP-MCAM
WM239a cells were morphologically similar to rounded MDA-
MB-231 breast carcinoma cells that were previously
characterized by cortical F-actin flow towards a pronounced
uropod-like structure [75,76] and A375 melanoma cells that
expressed an “ezrin-rich uropod-like structure (ERULS) [74].
Interestingly, the proposed mechanism for cortical flow towards
Figure 7.  HT-1080s and WM239a cells are characterized by rear-end MCAM-expressing uropod like structures.  Illustration
of uropod-like features and MCAM expression for tumor cells in synthetic ECM (220 Pa, 1000 μM CRGDS): (A-C) Z-projected
immunofluorescence images for a WM239a melanoma cell; (A) β1-integrin (green), counterstained with TRITC-conjugated
phalloidin (F-actin, red) and DAPI (nucleus, blue); Single channel images (grayscale) illustrate (B) Factin and (C) β1-integrin. (D)
Time-lapse images for a GFP-MCAM transfected WM239a melanoma cell (30 min / frame; See also Movie S13); Brightfield (top)
and GFP-MCAM expression (bottom). (E-G) Z-projected immunofluorescence images for a WM239a melanoma cell; (E) Melanoma
cell adhesion molecule (MCAM, green), counterstained with TRITC-conjugated phalloidin (F-actin, red) and DAPI (nucleus, blue);
Single channel images (grayscale) illustrate (F) Factin and (G) MCAM. (H) Time-lapse images for a GFP-MCAM transfected
HT-1080 cell (15 min / frame; Background pixel intensity subtracted using the “Math” function in ImageJ and uniformly applied to all
GFP images for better display); Brightfield (top) and GFP-MCAM expression (bottom).
doi: 10.1371/journal.pone.0081689.g007
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the uropod-like structure described for MDA-MB-231 cells
[75,76] resembled mechanisms that have been proposed to
facilitate cytokinesis [117-120]. MCAM was enriched on the
contractile ring during cytokinesis for dividing GFP-MCAM
WM239a cells, and remained pinned on the rear of each
migrating daughter cell at the site of abscission (Figure S9;
Movie S13). HT-1080s also expressed similar components on
the rear end structure and contractile ring (Figures S7 and S9),
suggesting that the uropod-like feature observed for tumor cells
may be structurally related to the cytokinesis machinery and/or
the midbody [72,121]. These combined results indicate that
uropod-like structures play a diverse role for invasive tumor
cells, and could provide an important mechanistic link between
aggressive tumorigenic cell types with diverse origins,
morphological features, and proteolytic requirements.
Several mechanistic similarities between migration and cell
division have been described [119,120,122-130], and genetic
signatures enriched with mitosis genes have been identified as
predictors of metastasis and poor survival for several human
cancers [131-133]. We identified a linear relationship between
cell division and average distance migrated for HT-1080s in
synthetic ECM (Figure S9E), which is consistent with a recently
reported correlation between proliferation and migration
distance for several malignant melanoma cell lines in 2D
culture [130]. The mitotic kinases Cdc2 (Cdk1) [127] and
Aurora-A [124] have been implicated in migration for
aggressive tumorigenic cell types, and it was suggested that
normal mitotic function for Cdc2 might be “hijacked” by tumor
cells to facilitate invasion [128]. Cdc2 is a regulator of mitosis
that plays a role in cytoskeletal reorganization [129,134,135],
and has been shown to directly induce cell rounding when
microinjected into fibroblasts [135]. Rounded HT-1080s
migrating on RGD-SAMs express Cdc2 similarly to dividing
cells, but not spread cells (Figure S10), which is consistent with
the previously reported role for Cdc2 in migration for
aggressive tumorigenic cell lines (including HT-1080s) [127].
Further, daughter HT-1080 cells retained a rounded
morphology and a polarized phenotype after mitosis (Figure
S9F; Movie S3), whereas hDFs extended multiple protrusions
during cytokinesis, while daughter cells appeared to migrate
more randomly (Figure S9G-H; Movie S16). More generally,
mitosis induces several changes in cell function that mirror
transformation (and several observations for HT-1080s here),
including reorganization of the F-actin cytoskeleton
[17,129,135,136], altered adhesiveness [32,137] and integrin
function [27,28,30,138], and regulation of external response to
growth factors [3,139]. While further investigation would be
required to definitively identify a role for mitosis or cytokinesis
signaling in tumor cell motility, we speculate that de-regulated
proliferation may abnormally alter migration mechanisms for
tumor cells with aggressive tumorigenic phenotypes.
Finally, membrane shedding has been implicated in tumor
progression due to transfer of genetic material, long range cell
signaling, suppression of the immune response, and
transformation of fibroblasts and epithelial cells [140-144].
HT-1080s shed cell fragments of various sizes in collagen and
synthetic ECM (Figures S4, S11; Movies S17, S18), including
larger features that were several microns in diameter (e.g.,
Figure S4D-F). HT-1080s also formed secondary protrusions
that split from the leading edge (Figure S11A-B; Movie S19)
and remained attached to the cell body through a pronounced
structure that resembled an intracellular bridge during
Figure 8.  Matrix influences on migration and morphologies for HT-1080s in synthetic ECM.  (A) Cell speed and (B)
directionality (DTO/TD) for HT-1080s as a function of matrix conditions (≥ 6 gels, ≥ 40 cells, at least two separate experiments; * =
p<0.05; ** = p<0.01). X-axis: Modulus in Pa / RGD concentration in μM. Box and whisker plot for cell speed: White diamond = mean,
white line = median, boxes = middle upper (top) and middle lower (bottom) quartile of the cell population, whiskers = highest (above)
and lowest (below) migration speeds. Error bars for DTO/TD represent standard error of the mean for individual cells. There is also
a statistical difference in cell speed for the 140 Pa (1500 μM RGD) and 220 Pa (250 μM RGD) conditions (p<0.05, not shown on
graph for clarity). (C) A comparison of the fraction of rounded HT-1080s (Elongation Index < 2.0) as a function of synthetic ECM
conditions (x-axis: Modulus in Pa / RGD concentration in μM; white bar = 140 Pa; black bars = 220 Pa). Error bars represent
standard deviation for fraction of rounded cells per gel (≥ 6 gels, at least two separate experiments; * = p<0.05; ** = p<0.01; *** =
p<0.001).
doi: 10.1371/journal.pone.0081689.g008
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Figure 9.  A comparison of quantified migration and morphologies for HT-1080s in synthetic ECM and collagen.  Migration
and morphologies were compared for HT-1080s cultured in lower modulus synthetic ECM (140 Pa, 1500 μM CRGDS) and collagen
(1.7 mg/mL, acid-extracted, rat tail collagen, BD Biosciences). Time-lapse microscopy (15 min / frame) illustrating HT-1080s
migrating in (A) synthetic ECM (also Movie S15) and (B) collagen (also Movie S9). Scale bars = 25 μm.
HT-1080s migrated in lower modulus synthetic ECM and collagen with statistically equivalent (C) speed and (D) directionality (DTO/
TD). Box and whisker plot for cell speed: White diamond = mean, white line = median, boxes = middle upper (top) and middle lower
(bottom) quartile of the cell population, whiskers = highest (above) and lowest (below) migration speeds. Differences in HT-1080
morphology were determined by comparing quantified (E) circularity and (F) fraction of rounded cells (Elongation < 2.0). Circularity
was calculated for individual cells (3 separate experiments, N > 200); Fraction of rounded cells was calculated per gel (at least two
separate experiments, N ≥ 3 gels), with error bars representing standard deviation (*** = p < 0.001).
doi: 10.1371/journal.pone.0081689.g009
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cytokinesis (Figure S11D). The secondary protrusion for
HT-1080s typically shifted around the cell body and was
retracted at the rear (Figure S11A-B; Movie S19). However,
protrusions often detached from the primary cell and migrated
independently despite lacking a nucleus, and similar
fragmenting was observed for HT-1080s in collagen (Figure
S11E-H; Movies S17, S18). “Independent motile microplasts”
(IMMPs) were previously identified for glioma cells in collagen,
and it was reported that these features migrated for several
days after being formed [144]. The frequency of IMMP
formation was reported to increase as a function of
invasiveness (based on a comparison of cell type) and ionizing
radiation [144], while our results identified a correlation to RGD
concentration (i.e., adhesion) for HT-1080s in synthetic ECM
(Figure S11G). Therefore, while little is currently known about
IMMPs, these large anucleate features facilitated all aspects of
proteolytic motility for HT-1080s in synthetic ECM, and
demonstrate a profoundly unstable phenotype that to the best
of our knowledge has not been observed for normal primary
cells.
Conclusion
Here, we compared migration and morphologies for HT-1080
fibrosarcoma cells and primary human dermal fibroblasts
(hDFs) using engineered culture platforms to provide defined
biochemical and biophysical matrix properties. In synthetic
ECM, hDFs were characterized by several features that were
consistent with those previously reported for fibroblasts in 3D
culture [92-98], including multipolar morphologies, organized
actomyosin filaments, and vinculin enrichment on the tips of
protrusions. HT-1080s were characterized by cytoskeletal and
adhesion properties that were distinct from hDFs in 2D and 3D
culture, including quantitatively more rounded morphologies,
decreased adhesiveness, and increased directional motility.
Rounded and elongated HT-1080s also migrated through
contractility-dependent, proteolytic mechanisms in synthetic
ECM, and were characterized by cortical F-actin expression,
cortex rupture and blebbing, cortical contraction waves or
constriction rings, and a prominent rear end uropod-like
structure. Our results demonstrate that HT-1080s adopt a
distinct phenotype compared to hDFs under a wide range of 2D
and 3D culture conditions.
Based on our results, we propose that aggressive
tumorigenic cell types migrate distinctly from normal primary
cells due to profound cellular changes induced by the
transformed phenotype. HT-1080s were characterized by
several features that were consistent with transformation,
including a cortically organized F-actin cytoskeleton [17-22],
diffuse vinculin expression [22-26], and a weakly-adherent
phenotype [26,30-36]. Further, HT-1080s formed “independent
motile microplasts (IMMPs)”, large migrating anucleate
fragments that were previously correlated to increased
invasiveness and exposure to ionizing radiation for glioma cells
[144], pointing to a highly unstable tumorigenic phenotype that
to the best of our knowledge has not been reported for primary
cell types. Rounded and elongated HT-1080s and WM239a
cells migrated through proteolytic modes and expressed
prominent uropod-like structures that were similar to features
reported for rounded A375 melanoma and MDA-MB-231 breast
carcinoma cells migrating through non-proteolytic mechanisms
[73-75]. Notably, HT-1080 fibrosarcoma cells, WM239a and
A375 melanoma cells, and MDA-MB-231 breast carcinoma
cells are each characterized by activating Raf or Ras mutations
[63-66,145,146]. Ras and Raf regulate many cellular processes
and are two of the most commonly mutated genes for
metastatic cancers [1,3,147-150]. Importantly, the N-Ras
mutation for HT-1080s disrupts cytoskeletal structure and
activates several signaling pathways important for migration,
including RhoA, Rac1, phosphoinositide 3-kinase (PI3K), and
mitogen-activated protein kinase (MAPK) [63-66]. We
speculate that activated signaling associated with mutated
oncogenes (such as Ras or Raf) induces abnormal overlap
between mechanisms that would otherwise be tightly regulated
(such as migration and mitosis, see Discussion). Therefore,
mutations common to metastatic cancers may provide a key
starting point for elucidating migration mechanisms unique to
aggressive tumorigenic cell types with diverse origins.
Supporting Information
Figure S1.  Quantified migration and morphologies for
HT-1080 fibrosarcoma cells (HT-1080s) and human dermal
fibroblasts (hDFs) in synthetic ECM. (A) A comparison of
directionality (DTO/TD, black) and persistence time (gray) as a
function of RGD concentration for HT-1080s cultured in
synthetic ECM (220 Pa). Distance-to-Origin (DTO) is the
distance a cell moves from the initial starting position after 6
hours of tracking. Total distance (TD) is the sum of all
individual movements during the 6 hours of tracking (15 min /
frame, see Schematic). Persistence (P) was determined by
fitting mean-squared displacement (MSD) data to a persistent
random walk model (Dickinson, R.B. and R.T. Tranquillo, Aiche
Journal 1993): .
MSD = 2S2P[t-P(1 - e-t/P)].
A sliding window algorithm was used to calculate mean
squared displacements (MSD) at 15 minute time intervals (t),
with speed (S) calculated as an unrestricted variable. All fits
had R2 > 0.9 and numbers obtained were within a 95%
confidence interval.
Quantified (B) cell speed and (C) DTO/TD as a function of
RGD concentration for HT-1080s compared at two different
matrix moduli (140 Pa and 220 Pa). (D) Average cell length as
a function of RGD concentration for HT-1080s (black) and
hDFs (gray). (E) Fraction of migrating HT-1080s (black) and
hDFs (gray) as a function of RGD concentration (modulus =
220 Pa; all cells). All experiments: (≥ 6 gels, ≥ 40 cells
migrating, at least two separate experiments).
(TIF)
Figure S2.  A comparison of morphologies for HT-1080s
and hDFs in collagen. HT-1080s (right) and hDFs (left)
encapsulated in collagen (Type I, rat tail collagen, BD
Biosciences) of varying densities (as labeled). (A-D) TRITC-
conjugated phalloidin (F-actin, red) and DAPI (nucleus, blue).
(E-I) Projected immunofluorescence images (Zeiss LSM Image
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Browser) illustrating β1-integrin (green), TRITC-conjugated
phalloidin (F-actin, red) and DAPI (nucleus, blue). Insets in (E)
and (F) illustrate HT-1080s from (I) and (G) on the same size
scale as the hDFs shown.
(TIF)
Figure S3.  Analysis of punctate β1-integrin features for a
human dermal fibroblast in synthetic ECM.
Immunofluorescence images illustrating a human dermal
fibroblast (hDF): (A) Overlay; (B) F-actin (red, phalloidin); (C)
β1-integrin (green). (D) Surface plot (Image J, “3D Surface
Plot” plugin, See Methods) for β1-integrin expression to
illustrate punctate features. (E) Illustration of the line profiles
plotted in (F-K). (F-K) Profiles generated using the “Plot
Profiles” command in Image J (grayscale pixel intensity on an
8-bit scale; 256 = saturation intensity). Features shown in (C)
are also pointed out in (D, F-H). The relative grayscale was
2-5X higher for the punctate features (Lines 1-3) than
maximum noise (Background 1-2).
(TIF)
Figure S4.  Influence of integrin blocking antibodies and
illustration of β1-integrin dynamics at the rear for
HT-1080s in synthetic ECM. Normalized quantified (A) cell
speed and (B) directionality (DTO/TD) for HT-1080s cultured in
synthetic ECM (220 Pa, 1000 μM CRGDS). HT-1080s were
treated with β1-integrin (Anti-b1) or β3-integrin (Anti-b3)
blocking antibodies and a combination of both (Anti-b1,b3). β1-
integrin blocking antibody (CD29, 6603113, Beckman Coulter)
was added to the hydrogel monomer solution during
polymerization (28 μg/mL final concentration) and to media (25
μg/mL final concentration) during swelling. For β3-integrin, 2 μL
blocking antibody reagent (as received, CD-61, IM3605,
Beckman Coulter) was added to monomer solution (PBS in
monomer solution was decreased by same amount) and 30 μL
was added to 1.5 mL media for overnight swelling. Media
containing integrin blocking antibodies were exchanged with
fresh solutions immediately prior to tracking migration. (C-F)
Immunofluorescence images illustrating morphologies and rear
end structures for HT-1080s cultured in synthetic ECM (220
Pa, 1000 μM CRGDS); β1-integrin (green), counterstained with
TRITC-conjugated phalloidin (F-actin, red) and DAPI (nucleus,
blue).
(TIF)
Figure S5.  Illustration of membrane folding and lateral
blebbing for HT-1080s in synthetic ECM. (A-B) Time-lapse
images for an HT-1080 in synthetic ECM that is characterized
by lateral blebbing (arrows) and pronounced wrinkling (See
also Movie S7, time in Hr:Min:Sec). (A) 1 min/frame (00:13:30
to 00:25:30, every 4th frame, from Movie S7). (B) 15 sec/frame
(00:27:30 to 00:36:15, from Movie S7). Due to a change in
procedure before revisions, synthetic ECM for the cell shown in
(A,B) was prepared using 20,000 M.W. 8-arm poly(ethylene
glycol)(PEG)-norbornene (40 mg/mL PEG-NB, 45% NB groups
crosslinked with MMP-degradable peptide, 500 μM CRGDS)
instead of 4-arm PEG-NB such as used for experiments shown
in primary manuscript figures (Schematic, Figure 1A). Synthetic
ECM was formed in roundbottom 96-well plates (7 μL / well) to
image cells immediately after encapsulation while minimizing
drift. Qualitatively similar results were obtained for
morphological characterization using both hydrogel
formulations. The HT-1080 in (A,B) is shown migrating in a
region of the synthetic ECM that had not previously been
degraded. Scale bars = 25 μm. (C-E) Immunofluorescence
images for HT-1080s cultured in synthetic ECM (220 Pa, 1000
μM CRGDS); β1-integrin (green), counterstained with TRITC-
conjugated phalloidin (F-actin, red) and DAPI (nucleus, blue).
(C) Membrane ridges characterized by co-localized β1-integrin
and F-actin were periodically expressed for HT-1080s in
synthetic ECM. Overlay image (left panel) represents a
projection of all planes (Zeiss Image Browser, maximum
transparency) while images in the three panels to the right
represent a single plane to better illustrate the radial features
on the cell membrane. (D-E) HT-1080s in synthetic ECM were
also characterized by membrane wrinkling (dashed boxes). (E)
The top row represents a projection of all planes (Zeiss Image
Browser, maximum transparency), while the bottom rows are
two consecutive single plane images. Brightfield insets: The
HT-1080 in Movie S7 (also A and B) is compared to IF images
during time frames that illustrate similar morphologies (time
stamp from Movie S7 shown).
(TIF)
Figure S6.  Illustration of bleb-like bulges on leading
protrusions for HT-1080s migrating in synthetic ECM.
Isotype control experiment comparing (A) rabbit myosin IIb
antibody and (B) rabbit IgG control. Samples were treated
using the procedure described in Methods (identical rabbit
antibody concentration, myosin IIb or IgG control); Both
samples were counterstained with Phalloidin (F-actin, red) and
DAPI (not shown so that nuclear staining can be visualized)
and then imaged using identical microscope settings. The IgG
control antibody did not produce observable fluorescence,
indicating that there was minimal expression due to non-
specific effects. Therefore, myosin IIb expression within the
nucleus and in the extracellular space is likely due to specific
expression.
(C-O) Myosin II expression for HT-1080 cultured in synthetic
ECM (220 Pa, 1000 μM CRGDS) (C) Z-projected
immunofluorescence image illustrating myosin IIb (green),
counterstained with TRITC-conjugated phalloidin (F-actin, red)
and DAPI (nucleus, blue). Myosin II immunofluorescence
expression for (D) Z-projection and (E-I) consecutive single
planes. F-actin expression for (J) Z-projection and (K-O)
consecutive single planes.
(P-T) Z-projected immunofluorescence image illustrating
HT-1080s cultured in synthetic ECM (220 Pa, 1000 μM
CRGDS): (P) MT1-MMP (MMP-14, green), counterstained with
TRITC-conjugated phalloidin (F-actin, red) and DAPI (nucleus,
blue). Single channel images for (Q) F-actin and (R) MT1-
MMP. Images generated using ImageJ “Interactive 3D Surface
Plot” function (“Fire” intensity scale) for (S) F-actin and (T)
MT1-MMP.
(U) Expansion and contraction of bleb-like pseudopod on the
front tip for an HT-1080 migrating in synthetic ECM (1 min /
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frame; 40 mg/mL 8-arm PEG-NB, 45% MMP crosslinks, 500
μM CRGDS; See also, Movie S6). Scale bar = 25 μm. Right
two panels: Comparison of (V) cell from time lapse images in
(U) with (W) myosin IIb-expressing cell from (C).
(TIF)
Figure S7.  Uropod-like features and MCAM expression for
tumor cells in synthetic ECM. Z-projected
immunofluorescence images (Zeiss LSM Image Browser,
maximum transparency) for tumor cells in synthetic ECM (220
Pa, 1000 μM CRGDS unless otherwise noted). (A) WM239a
melanoma cell: Melanoma cell adhesion molecule (MCAM/
cd146/MUC18, green), counterstained with TRITC-conjugated
phalloidin (F-actin, red) and DAPI (nucleus, blue). Image
represents the rear of a cell that is oriented into the plane. Thin
F-actin filaments appear to propagate radially from the uropod-
like structure (white arrows). (B) WM239a melanoma cell:
Myosin IIb (green), counterstained with TRITC-conjugated
phalloidin (F-actin, red) and DAPI (nucleus, blue). Note that
myosin IIb is expressed on the rear end uropod-like structure.
(C,D) HT-1080 fibrosarcoma cells: Melanoma cell adhesion
molecule (MCAM/cd146/MUC18, green), counterstained with
TRITC-conjugated phalloidin (F-actin, red) and DAPI (nucleus,
blue). HT-1080s shown in (C,D) were encapsulated in synthetic
ECM formed with an 8-arm PEG-NB crosslinker (40,000 MW)
with mechanical properties that were similar to the 4-arm PEG-
NB used for most experiments. (E) HT-1080 fibrosarcoma
cells: β1-integrin (green), counterstained with TRITC-
conjugated phalloidin (F-actin, red) and DAPI (nucleus, blue).
Cells shown in (D) and (E) illustrate similar morphological
features and localization of MCAM and β1-integrin for apparent
migrating daughter cells after cell division.
(TIF)
Figure S8.  A comparison of 2D morphologies for HT-1080s
and hDFs. (A,B) HT-1080s and (C,D) hDFs on RGD-SAMs
(0.6% and 5% mol fraction RGD; Scale bar = 50 μm, A-D
shown at the same magnification, except inset). Inset for (A)
compares HT-1080s on RGD-SAM and in synthetic ECM (box
= 30 x 30 μm). (E) Projected cell area for HT-1080s as a
function of RGD density on RGD-SAMs. Error bars represent
standard error of the mean for individual cells (* = p<0.05; ** =
p<0.01). (F) HT-1080s and (G) hDFs on tissue culture
polystyrene (TCP). (H) A comparison of migrating HT-1080s in
synthetic ECM (3 wt% 20,000 MW 8-arm PEG-NB; 50% MMP
crosslinks; 1 mM CRGDS) and on an RGD-SAM surface (1.7%
RGD mol fraction). (I) hDFs on 0.02% mol fraction RGD-SAM
spread and formed focal adhesions (HT-1080s did not attach at
0.02% mol fraction RGD). All immunofluorescence images
illustrate vinculin (green), counterstained with phalloidin (F-
actin, red) and DAPI (nucleus, blue).
(TIF)
Figure S9.  Polarity and cell division for cells in synthetic
ECM. (A) MCAM expression for a dividing GFP-MCAM
WM239a melanoma cell. Upon completion of cell division,
MCAM remains pinned on the rear of migrating daughter cells
(See also, Movie S13). HT-1080s express myosin IIb on (B)
the contractile ring and (C) the rear-end uropod like feature.
Myosin IIb was expressed more clearly on the uropod-like
feature for WM239a cells (e.g., Figure S7B). (D)
Immunofluorescence images illustrating β1-integrin (green),
counterstained with TRITC-conjugated phalloidin (F-actin, red)
and DAPI (nucleus, blue) for a dividing HT-1080. (E) Average
distance migrated (DTO, all cells) vs. cell division for HT-1080s
in synthetic ECM (220 Pa, 250-1500 μM CRGDS). Average
DTO was calculated for all cells (not just migrating cells), and
provides a measure of effective invasiveness that accounts for
speed and directionality. Successful cell division was defined
as cells that rounded, formed a cleavage ring, and then
separated into two distinct daughter cells. Migration and cell
division were compared for the same 6 hour time course. Cells
that began cell division before the 6 hours of tracking, or did
not first undergo mitotic rounding, were not counted. There was
a linear correlation between average DTO and successful cell
division. Error bars represent standard error of the mean for
individual hydrogels (≥ 8 gels, three separate experiments). (F)
Time-lapse images (10 min / frame, Movie S3) illustrating a
dividing HT-1080 in synthetic ECM (220 Pa, 1000 μM CRGDS).
(G) Immunofluorescence images illustrating β1-integrin (green),
counterstained with TRITC-conjugated phalloidin (F-actin, red)
and DAPI (nucleus, blue) for a dividing hDF. (H) Time-lapse
images (15 min / frame, also Movie S16) illustrating a dividing
hDF in synthetic ECM (220 Pa, 1000 μM CRGDS). Notably, the
hDF in (G) has begun to form substantial protrusions while the
contractile ring is still prominent, which is consistent with time-
lapse images in (H). Daughter HT-1080 cells (D) remain
polarized and migrate persistently for several hours after
division.
(TIF)
Figure S10.  Cdc2 expression for HT-1080s on RGD-SAMs.
(A) Time-lapse images (15 min / frame) illustrating HT-1080s
on an RGD-SAM surface (1.7% mol fraction RGD). (B,C)
Immunofluorescence images illustrating Cdc2 (Green),
counterstained with TRITC-conjugated phalloidin (F-actin, red)
and DAPI (nucleus, blue). Cells in (A) were fixed and are
shown in (B). Images in (C) provide a broad overview for
rounded and spread HT-1080s. Inset in (C) illustrates nuclei
(DAPI) for cells during mitosis.
(TIF)
Figure S11.  HT-1080s adopt unstable phenotypes in 3D
matrices. (A,B) HT-1080s formed pronounced secondary
protrusions (white arrows) that eventually retracted into the rear
of the cell (See Movie S19). (C) Z-projected
immunofluorescence images (Zeiss LSM Image Browser) for
an HT-1080 in synthetic ECM (220 Pa, 1000 μM CRGDS)
illustrating: Myosin IIb (green), counterstained with TRITC-
conjugated phalloidin (F-actin, red) and DAPI (nucleus, blue).
Rainbow intensity images are shown (to the right of false color
images) to aid visualization of myosin IIb in the retracting
feature at the rear of the cell. (D) Three separate z-projected
immunofluorescence images (Zeiss LSM Image Browser) for
HT-1080s in synthetic ECM (220 Pa, 1000 μM CRGDS)
illustrating secondary features of various sizes; β1-integrin
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(green), counterstained with TRITC-conjugated phalloidin (F-
actin, red) and DAPI (nucleus, blue). (E) Time-lapse images (1
hour / frame, inset = 15 min / frame; also Movie S17) illustrating
formation of an “independent motile microplast” (IMMP, see
Yount et. al, J. Neuro.-Oncol. 2007). Hydrogel was fixed and
stained with DAPI (insets, final frame) to demonstrate that a
nucleus was absent in the IMMP. (F) Immunofluorescence
images illustrating an HT-1080 and an apparent IMMP in
synthetic ECM (220 Pa, 1000 μM CRGDS); β1-integrin (green),
counterstained with TRITC-conjugated phalloidin (F-actin, red)
and DAPI (nucleus, blue). Image suggests that the IMMP
migrated prior to fixing due to a trail of β1-integrin leading away
from the HT-1080 containing a nucleus. Anucleate features of
various sizes were common for HT-1080s, although motility
cannot be definitively determined for IF images alone. (G) The
fraction of HT-1080s characterized by abnormal fragmenting
consistent with IMMP formation was proportional to RGD
concentration (above 125 μM CRGDS). Cells were analyzed
during the same 6 hour time period used for quantifying
migration and cell division. Apparent IMMPs were determined
based on cells that did not stop or exhibit rounding before
splitting into two migrating features, as would be expected for
normal cell division. While several IMMPs were confirmed by
fixing and DAPI staining, most of the secondary features used
for quantification were unconfirmed. (H) A migrating HT-1080 in
collagen (15 min / frame) splits into two motile fragments
without mitotic rounding (also Movie S18). IMMP formation was
not confirmed in collagen, and therefore could be due to other
abnormal cell division phenomena.
(TIF)
Movie S1.  Treatment with matrix metalloproteinase
inhibitor (GM6001) blocks migration for HT-1080
fibrosarcoma cells in synthetic ECM. Time-lapse images (15
min / frame) illustrating HT-1080s migrating in synthetic ECM
(220 Pa, 1000 μM CRGDS) after treatment with DMSO
(control, left) or matrix metalloproteinase (MMP) inhibitor
(GM6001, right). Images represent minimum intensity z-
projections (middle 500 μm of ~1000 μm thick matrix).
HT-1080s are shown for the same time frame used for tracking
and quantification of motility. No HT-1080s moved more than
one cell length after treatment with MMP-inhibitor,
demonstrating that proteolysis is required for migration in
synthetic ECM. Time shown in Hr:Min. Scale bar = 100 μm.
(AVI)
Movie S2.  Human dermal fibroblast migrating in synthetic
ECM. Time-lapse images (10 min / frame) for a human dermal
fibroblast (hDF) migrating in synthetic ECM (220 Pa, 1000 μM
CRGDS). The hDF illustrated here is shown in Figure 3A
(movie shown without image processing). Movement is
consistent with hDF extension, attachment, cell body
translocation, and rear end release (see Figure 3A). Time
shown in Hr:Min. Scale bar = 25 μm.
(AVI)
Movie S3.  HT-1080 fibrosarcoma cell division and
migration of daughter cells in synthetic ECM. Time-lapse
images (10 min / frame) illustrating cell division for an HT-1080
fibrosarcoma cell and migration of daughter cells in synthetic
ECM (220 Pa, 1000 μM CRGDS). The same dividing HT-1080
is also illustrated in Figure S9F, and the daughter cell migrating
towards the bottom, left is shown in Figures 3B (relationship
between rear retraction and leading edge extension) and 5A
(constriction ring formation). The cell migrating towards the top,
right also illustrates formation of a split protrusion and
retraction at the rear (beginning at 2:59, frame 19). Time shown
in Hr:Min. Scale bar = 25 μm.
(AVI)
Movie S4.  Human dermal fibroblasts and HT-1080
fibrosarcoma cells migrating in synthetic ECM. Time-lapse
images (15 min / frame) illustrating human dermal fibroblasts
(left) and HT-1080 fibrosarcoma cells (right) migrating in
synthetic ECM (220 Pa, 1000 μM CRGDS). Images represent
minimum intensity z-projections (200 μm stacks in the middle of
~ 1000 μm thick hydrogels). Time shown in Hr:Min. Scale bar =
100 μm.
(AVI)
Movie S5.  Blebbing on the leading protrusion for an
HT-1080 fibrosarcoma cell migrating in synthetic ECM.
Time-lapse images (15 sec / frame) for an HT-1080
fibrosarcoma cell migrating in synthetic ECM (40 mg/mL
20,000 MW 8-arm PEG-NB, 50% MMP-degradable
crosslinking density, 500 μM CRGDS). Time shown in
Hr:Min:Sec. Scale bar = 25 μm.
(AVI)
Movie S6.  Dynamics of expanding and contracting bleb-
like leading pseudopodia and corresponding movement of
the cell body for an HT-1080 fibrosarcoma cell migrating in
synthetic ECM. Time-lapse images (60 sec / frame) for an
HT-1080 fibrosarcoma cell migrating in synthetic ECM (40
mg/mL 20,000 MW 8-arm PEG-NB, 50% MMP-degradable
crosslinking density, 500 μM CRGDS). Semi-spherical bleb-like
bulges form at the leading edge as the cell body cortically
contracts (e.g., 16:00-28:00). The rear of the cell moves
forward as the bleb-like feature contracts (e.g., 29:00-36:00).
The same HT-1080 is also illustrated in Figure S6U. Time
shown in Min:Sec. Scale bar = 25 μm.
(AVI)
Movie S7.  Protrusion expansion, blebbing and cortex
compression for an HT-1080 fibrosarcoma cell migrating in
synthetic ECM. Time-lapse images (15 sec / frame) for an
HT-1080 in synthetic ECM (40 mg/mL 20,000 MW 8-arm PEG-
NB, 45% crosslinking with MMP-degradable peptide, 500 μM
CRGDS). The HT-1080 shown here is characterized by cell
body and lateral blebbing, pronounced wrinkling, and
expansion of the leading protrusion. The three frames (from the
left) represent consecutive focal planes, while the last frame
(far right) is a minimum intensity z-projection. The same
HT-1080 is illustrated in Figure S5. Time shown in Hr:Min:Sec.
Scale bar = 25 μm.
(AVI)
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Movie S8.  HT-1080 fibrosarcoma cells migrating on RGD-
functionalized self-assembled monolayer (RGD-SAM)
surface. Time-lapse images (30 sec / frame) illustrating
HT-1080 fibrosarcoma cells migrating on an RGD-SAM surface
(1.7% mol. fraction GRGDSP). Time shown in Hr:Min:Sec.
Scale bar = 25 μm.
(AVI)
Movie S9.  HT-1080 fibrosarcoma cells migrating in 1.7
mg/mL collagen. Time-lapse images (15 min / frame) for a
single image plane illustrating HT-1080s migrating in 1.7
mg/mL collagen (BD Biosciences, High concentration rat tail
collagen). The same HT-1080 is illustrated in Figure 5B
(03:45-04:45). Time shown in Hr:Min. Scale bar = 50 μm.
(AVI)
Movie S10.  Treatment with myosin II inhibitor
(Blebbistatin) inhibits migration for HT-1080 fibrosarcoma
cells in synthetic ECM. Time-lapse images (15 min / frame)
illustrating HT-1080s migrating in synthetic ECM (220 Pa, 1000
μM CRGDS) after treatment with DMSO (control, left) or
myosin II inhibitor (10 μM Blebbistatin, right). Images represent
minimum intensity z-projections (middle 500 μm of ~1000 μm
thick matrix). Time shown in Hr:Min. Scale bar = 50 μm.
(AVI)
Movie S11.  HT-1080 fibrosarcoma cell migrating in
synthetic ECM with a rounded morphology (day 1). Time-
lapse images (15 min / frame) for a rounded HT-1080
fibrosarcoma cell migrating in synthetic ECM (220 Pa, 1000 μM
CRGDS). The same HT-1080 is illustrated in Figure 6A. Time
shown in Hr:Min. Scale bar = 50 μm.
(AVI)
Movie S12.  HT-1080 fibrosarcoma cell migrating in
synthetic ECM with a rounded morphology (day 0). Time-
lapse images (10 min / frame) for a rounded HT-1080
fibrosarcoma cell migrating in synthetic ECM (220 Pa, 1000 μM
CRGDS). The HT-1080 is shown during initial migration after
encapsulation. The same HT-1080 is illustrated in Figures 4G
and 6C. Time shown in Hr:Min. Scale bar = 25 μm.
(AVI)
Movie S13.  GFP-MCAM WM239a melanoma cell division
and migration of daughter cells in synthetic ECM. Time-
lapse images (30 min / frame) illustrating cell division for GFP-
MCAM transfected WM239a melanoma cell and migration of
daughter cells in synthetic ECM (220 Pa, 1000 μM CRGDS);
Brightfield (top) and GFP-MCAM (bottom). During cell division,
MCAM became delocalized, and was then re-expressed on the
cleavage ring during cytokinesis. MCAM remained pinned on
the rear for each daughter cell at the point of cleavage,
suggesting a possible relationship to the cytokinesis machinery
or midbody. Time shown in Hr:Min. Scale bar = 20 μm.
(AVI)
Movie S14.  HT-1080 fibrosarcoma cells in synthetic ECM
with non-bioactive RDG peptide (0 RGD, non-adhesive).
Time-lapse images (15 min / frame) illustrating HT-1080s
immobilized in synthetic ECM with non-bioactive pendant
peptide (220 Pa, 1500 μM CRDGS, 0 μM CRGDS). Images
shown for a single plane in the middle of a ~1000 μm thick
hydrogel. No HT-1080s moved more than one cell length in
non-adhesive synthetic ECM (at least 6 hours of tracking).
Time shown in Hr:Min. Scale bar = 100 μm.
(AVI)
Movie S15.  HT-1080 fibrosarcoma cells migrating in 140
Pa synthetic ECM. Time-lapse images (15 min / frame)
illustrating HT-1080 fibrosarcoma cells migrating in lower
modulus synthetic ECM (140 Pa, 1500 μM CRGDS). Images
represent minimum intensity z-projections (300 μm thickness in
the middle of ~1000 μm thick matrix). Time shown in Hr:Min.
Scale bar = 100 μm.
(AVI)
Movie S16.  Cell division for a human dermal fibroblast in
synthetic ECM. Time-lapse images (15 min / frame) illustrating
cell division for a human dermal fibroblast (hDF) in synthetic
ECM (220 Pa, 1000 μM CRGDS). The same hDF is illustrated
in Figure S9H. The hDF begins to form protrusions before
daughter cells complete abscission, while the separating cells
migrate in an apparent random fashion that is distinct from
polarized HT-1080s (Movie S3) or WM239a cells (Movie S10).
Time shown in Hr:Min. Scale bar = 25 μm.
(AVI)
Movie S17.  HT-1080s form independent motile microplasts
(IMMPs) in synthetic ECM. Time-lapse images (15 min /
frame) illustrating the formation of an “independent motile
microplast” (IMMP, see Yount et. al., J. Neuro-Oncol. 2007) by
a migrating HT-1080 in synthetic ECM (220 Pa, 1000 μMm
CRGDS). Synthetic ECM was fixed immediately after last time
point and stained with DAPI to demonstrate that one cell
retained a nucleus while the other was an IMMP (See Figure
S10E). Time shown in Hr:Min. Scale bar = 50 μm.
(AVI)
Movie S18.  HT-1080s split into multiple migrating cells or
cell fragments in collagen. Time-lapse images (15 min /
frame) illustrating a migrating HT-1080 in collagen (1.7 mg/mL)
that splits into two motile fragments without mitotic rounding
(also Figure S10H). The formation of multiple motile fragments
by HT-1080s during migration resembled IMMP formation (see
Yount et. al., J. Neuro-Oncol. 2007) such as demonstrated in
synthetic ECM (Movie S17). However, IMMP formation was not
confirmed in collagen, and therefore the observations shown
here could be due to other abnormal cell division phenomena.
Time shown in Hr:Min. Scale bar = 50 μm.
(AVI)
Movie S19.  Abnormal protrusion dynamics for an HT-1080
in synthetic ECM. Time-lapse images (10 min / frame)
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illustrating protrusion dynamics for an HT-1080 migrating in
synthetic ECM (220 Pa, 1000 μM CRGDS). The same HT-1080
is illustrated in Figure S10B. The HT-1080 shown here forms
protrusions that split into pronounced features resembling
IMMPs (Movie S17), but retracted back into the migrating cell.
Time shown in Hr:Min. Scale bar = 25 μm.
(AVI)
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